CyGene Laboratories, Inc., a South Florida Genetics Company, Creates DNA Testing for the Masses, to Determine What Form of Exercise Works Best for ``You''.

MIAMI -- Imagine a world where one small analysis can establish how to look and perform your best. A futuristic test that can help determine which form of exercise will make you look you're slimmest and perform your best at sports. A revolutionary assessment of how to lose weight through exercise, and keep it off -- making your inexhaustible 'battle of the bulge' end permanently. Fortunately, new scientific advances have transformed conventional ways of assessing fitness, allowing for better faster results through diet and exercise.

CyGene Laboratories, Inc., (OTC:CYGE) a company based in Coral Springs, Florida, has developed a remarkable new DNA test called the "Optimum Athletic Performance DNA Analysis," which is designed to determine what form of training, based on an individual's DNA predisposes them to a better results-oriented work-out.

Recent scientific evidence suggests that a number of genes play a role in athletic performance, and that muscle growth, cardiac output and other factors influence the physical performance associated with these different genes carried by all individuals.

This amazingly insightful analysis concludes whether endurance or speed athletics are individually a better form of exercise, and in turn, help the exerciser focus on how to maximize their work-out for the best possible outcome. In addition, this analysis can determine the potential for sports related injury, by testing bone strength and neurological pre-dispositions.

"Athletes could soon have their training program and diet optimised for peak performance and minimal injuries based on their individual genetics," says Professor Mark Hargreaves, from the Physiology Department at the University of Melbourne, Australia, and the Chair of the Sports Meets Science Forum. Designing an exercise regimen best suited to an individual is currently based on trial and error. "You can give the same exercise program to 700 individuals and get a very divergent response. The new tools of molecular biology are giving us greater insight into a person's physiology."

CyGene has made this DNA test easily available for everyone. The test is anonymous, ensuring confidentiality, and it can be purchased at the low price of $99.95 online at http://www.cygenedirect.com. There is no need to enter a doctor's office or a testing center. A home test kit is delivered to your door, and includes a cheek swab which can be easily mailed back to CyGene's laboratories. Accessing the results is equally as simple and is done through a personalized online report which contains interpretations of individual genes, including potential risks, follow-ups, and recommendations.

About CyGeneDIRECT

CyGeneDIRECT is an online consumer website that provides individuals with education and the opportunity to decide whether genetic testing is right for them. Individuals are able to purchase genetic test kits from a third party fulfillment center and retrieve their results anonymously in a comprehensive personalized report available on a secure server. The reports help them to understand how their personal genetics affect certain risks, how other factors contribute in combination with their genetic profile, and how to modify these factors to decrease their risk. For more information on CyGeneDIRECT, please visit http://www.cygenedirect.com.

About CyGene Laboratories, Inc.

CyGene Laboratories Inc., based in Coral Springs, Florida, is a biotechnology company focused on commercializing genetic and diagnostic testing, as well as developing therapies for infectious, genetic and autoimmune diseases. CyGene's scientific base rests on its Haystack Processing technologies, which it has been developing since 1995. As a result of its work on Haystack Processing, the Company has achieved significant technological breakthroughs that have led to the discovery of its other platform technologies. CyGene believes its patented technologies have promise in the discovery, development and utilization of cutting edge diagnostics based on synthetic DNA and therapeutics based on the rapid clearance of pathogens from the blood.

Forward-Looking Statements:

The statements made in this news release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Additionally words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions are forward-looking statements within the meaning of the Act. Some or all of the results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include, but are not limited to, when or whether the audits of our financial statements will be completed and audit opinions issued, due to unforeseen circumstances or unforeseen issues that may arise during the course of such audits. CyGene Laboratories Inc. has no duty and undertakes no obligation to update such statements. You should independently investigate and fully understand all risks before making investment decisions.